About Epithelial cell adhesion molecule
Epithelial cell adhesion molecule (EPCAM) is a protein
from Homo sapiens identified by UniProt accession
P16422, 314 residues long.
MolForge cross-references it against 0 known binders and
621 disease associations.
Target properties
| Protein name | Epithelial cell adhesion molecule |
| UniProt accession | P16422 |
| Gene | EPCAM |
| Organism | Homo sapiens |
| Length | 314 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (621)
Diseases linked to this target (Open Targets).
- congenital diarrhea 5 with tufting enteropathy · score 0.73
- Lynch syndrome 8 · score 0.72
- Intestinal epithelial dysplasia · score 0.71
- gastric cancer · score 0.54
- hereditary nonpolyposis colorectal carcinoma · score 0.52
- Lynch syndrome · score 0.50
- neoplasm · score 0.50
- colon carcinoma · score 0.43
- hereditary neoplastic syndrome · score 0.42
- Inherited cancer-predisposing syndrome · score 0.42
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P16422-F1 | alphafold | PREDICTED | 87.20 | — |
Amino-acid sequence (314 residues)
MAPPQVLAFG LLLAAATATF AAAQEECVCE NYKLAVNCFV NNNRQCQCTS VGAQNTVICS KLAAKCLVMK AEMNGSKLGR RAKPEGALQN NDGLYDPDCD ESGLFKAKQC NGTSMCWCVN TAGVRRTDKD TEITCSERVR TYWIIIELKH KAREKPYDSK SLRTALQKEI TTRYQLDPKF ITSILYENNV ITIDLVQNSS QKTQNDVDIA DVAYYFEKDV KGESLFHSKK MDLTVNGEQL DLDPGQTLIY YVDEKAPEFS MQGLKAGVIA VIVVVVIAVV AGIVVLVISR KKRMAKYEKA EIKEMGEMHR ELNA
Explore Epithelial cell adhesion molecule with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets